Managing Diarrhea from Chemotherapy in Colorectal Cancer
Author Information
Author(s): Maroun J.A., Anthony L.B., Blais N., Burkes R., Dowden S.D., Dranitsaris G., Samson B., Shah A., Thirlwell M.P., Vincent M.D., Wong R.
Primary Institution: Ottawa Hospital Regional Cancer Centre
Hypothesis
What is the optimal approach to managing chemotherapy-induced diarrhea (CID) in colorectal cancer patients?
Conclusion
A systematic approach to managing chemotherapy-induced diarrhea can reduce its severity and improve patient outcomes.
Supporting Evidence
- Diarrhea can occur in up to 82% of patients receiving chemotherapy.
- Severe diarrhea can lead to hospitalization and treatment modifications.
- Prophylactic measures may help reduce the incidence of severe diarrhea.
Takeaway
Chemotherapy can cause diarrhea, which can be really bad for patients, but there are ways to help them feel better and keep their treatment on track.
Methodology
The recommendations are based on expert opinion and retrospective analyses of patient data.
Potential Biases
Potential bias due to reliance on expert opinion and retrospective data.
Limitations
Many recommendations are based on clinical observation rather than randomized trials.
Participant Demographics
Patients with colorectal cancer undergoing chemotherapy.
Want to read the original?
Access the complete publication on the publisher's website